Sign in
4

Changes in Ownership

Vor Biopharma Inc. Filed Acc 0001415889-24-002096

CHIEF FINANCIAL OFFICER acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jorgensen Nathan D. CHIEF FINANCIAL OFFICER 2024-01-29 Grant or award +50,000 198,449 D
Derivatives
Jorgensen Nathan D. CHIEF FINANCIAL OFFICER 2024-01-29 Grant or award · Employee Stock Option (right to buy) +100,000 100,000 D
Loading xslF345X05/form4-02012024_120227.xml…